Better stem cell harvest: new combo may beat standard for myeloma patients
NCT ID NCT05517213
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different drug combinations to collect stem cells from 62 multiple myeloma patients before a stem cell transplant. The goal was to see which method works better and causes fewer side effects. Results could help more patients successfully move forward with transplant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital 307
Beijing, Beijing Municipality, 100071, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact